Clinical Trial Results: Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Evorpacept (ALX148) combined with cetuximab and pembrolizumab in refractory microsatellite stable metastatic colorectal cancer; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Microsatellite-stable Colorectal Cancer

Drugs mentioned

• Evorpacept (ALX148)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Microsatellite Stable Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-07-22